<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In 31 patients of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t was the commonest subtype (29%), and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>, the lease common (6.4%); 19.4% were characterised as the unclassifiable (UC) group </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000980'>Pallor</z:hpo> was the dominant sign (90.3%) </plain></SENT>
<SENT sid="2" pm="."><plain>Low <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> in RA &amp; <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e> (p&lt;0.05), <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t (p&lt;0.01) and high leuco/monocyte counts in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> (p&lt;0.001) were observed </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001875'>Neutropenia</z:hpo> occurred most frequently in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> &amp; <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t and circulating blasts in <z:hpo ids='HP_0000001'>all</z:hpo> cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Bicytopenia was the commonest finding (58.1%) and <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> the least (16.1%) </plain></SENT>
<SENT sid="5" pm="."><plain>84% of marrows were hypercellular and trilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> was seen in 68% of patients </plain></SENT>
<SENT sid="6" pm="."><plain>Megaloblastoid dyserythropoiesis was the predominant feature in <z:hpo ids='HP_0000001'>all</z:hpo> cases, dysgranulopoiesis in <z:hpo ids='HP_0000001'>all</z:hpo> cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>, and micromegokaryocytes in <z:hpo ids='HP_0000001'>all</z:hpo> cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> &amp; <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> were seen </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> (33.3% each) were the predominant groups which progressed to <z:hpo ids='HP_0001909'>leukemia</z:hpo>, FAB <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M2, being the commonest type (60%) </plain></SENT>
</text></document>